Therapeutic Approaches to Diabetes Flashcards

1
Q

primary energy source for all tissues?

A

Glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Uptake of blood glucose for energy utilization is in which two tissues?

A

Skeletal muscle

Brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Uptake of blood glucose for energy storage is in which tissues?

A

Liver

Adipose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Blood glucose excretion is in which tissue?

A

Kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens to glucose in a calorie deficit? (2)

A
Glycogen breakdown (glycogenolysis)
Glucose synthesis (gluconeogenesis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Blood glucose:
variable or non-variable?
wide or narrow range?

A

Variable

Narrow range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What tissue is critical for glucose homeostasis?

A

Pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The pancreatic islet of langerhans contains which two cells? They release which hormone/substance and under what condition (high or low glucose)

A

alpha : glucagon at low blood glucose levels

beta : insulin at high blood glucose levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Primary target or alpha cells? (1)

A

hepatocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Primary target for beta cells? (3)

A

Liver
Fat
Skeletal muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Insulin is what type of hormone?

A

Anabolic polypeptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Insulin is cleaved by intracellular ______ to generate which two chains? They remain linked by what?

A

proteases
A chain and B chain
Linked by 2 disulfide bridges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

4 steps leading to glucose-stimulated insulin secretion (GSIS)

A
  1. Glucose enters via GLUT2 and is metabolized, elevates [ATP]
  2. Elevated ATP inhibits ATP-sensitive K+ channels
  3. Depolarization and opening and voltage-gated Ca2+ channel
  4. Increased intracellular Ca2+ results in exocytic secretion of insulin from storage vesicles into the blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GLUT2 only transports glucose under what condition?

A

low affinity

>6mM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Blood insulin levels parallel _______ levels

A

blood glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diabetes Mellitus causes what? (2)

What does DIABETES and MELLITUS reference to in this disease?

A

Rapid weight loss
Excessive urination
Diabetes : copious amounts of urine production
Mellitus: sweet taste or smell of urine produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Diabetes Mellitus disorders are all characterized by what?

A

high blood glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Two primary causes of diabetes mellitus?

A

Inadequate insulin secretion

Impairment of insulin action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

type I diabetes is the most or least common type of diabetes?
It is the destruction of what?
there is reduced/absence of ________

A

Least common
Pancreatic beta cells
insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Type II diabetes is the most or least common type of diabetes?
The tissues are ______ to insulin
Advanced stages associated with __________ insulin secretion

A

Most common
resistant
insufficient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q
Type I diabetes is the loss of insulin production and GSIS : 
\_\_\_\_\_\_ glucose uptake
\_\_\_\_\_\_ glucose storage
Failure to inhibit \_\_\_\_\_ production
Low or high levels of blood glucose?
A

Reduced
Reduced
Glucose production
Elevated blood glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Acute effects of Type I and Type II diabetes? (5)

A
Excessive urine production
Extreme thirst/hunger
Rapid HR
Nausea, dizziness, confusion
Weakness, shaking, fainting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Chronic Complications of Type I and Type II diabetes? (8)

A
  1. Weight loss
  2. Damage to blood vessels in eyes
  3. Damage to blood vessels in extremities
  4. Kidney damage
  5. Peripheral nerve damage
  6. Hyperlipidemia
  7. Hypertension
  8. CV disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Treatments of Type I diabetes? (2)

Even with good management of hyperglycemia, is there still risk of chronic complications?

A

Diet
Insulin replacement
Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Type II diabetes is characterized by insulin resistance by the tissues:
____ glucose uptake and energy storage
____ liver glucose synthesis and release
Chronic _______

A

Reduced
Increased
Hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Lifestyle changes to treat Type II diabetes? (3)

A

Diet
Exercise
Weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

6 drugs to treat type II diabetes?

A
Metformin
Insulin secretagogues
Incretin agents
Gliflozins
Thiazolidinediones
Insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

4 types of insulin/insulin analogues?

A

Regular insulin
Insulin ispro
NPH insulin
Insulin Glargine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

2 insulin secretagogues?

A

Glyburide (sulfonylurea)

Rapaglinide (meglitinide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

2 Incretin agents?

A

Sitagliptin

Exetanide

31
Q

2 Gliflozins?

A

Dapagliflozin

Canagliflozin

32
Q

2 Thiazolidinediones?

A

Avandia (rosiglitazone)

Actos (pioglitazone)

33
Q

Insulin replacement therapy is always required in type ____ diabetes

A

I

34
Q

When is Insulin replacement therapy only used on type II diabetics?
Most common in severe cases where what happens?

A

When other therapies fail to provide adequate blood glucose control
Chronic hyperglycemia leads to beta cell destruction and impaired insulin secretion

35
Q

Only mode of insulin administration?

A

Injection

36
Q

Insulin pharmacokinetics are primarily determined by what?

A

absorption

37
Q

Steps of pharmacokinetics of insulin injection/absorption? (3)

A
  1. Injection creates subcutaneous depot of insulin at injection site
  2. Natural insulin molecules self-associate to form hexamers
  3. Hexamer dissociation for absorption
38
Q

Rate of insulin absorption determines what? (3)

A

Onset of action
Peak activity
Duration of action

39
Q

Slow insulin absorption:
Slow/long onset of action?
Slow/long duration?

A

Slow

Long

40
Q

Rapid insulin absorption:
Slow/long onset of action?
Slow/long duration?

A

Rapid

Short

41
Q

Natural insulin:
What configuration?
slow, normal or rapid absorption?
Onset is how long? peak? duration?

A
•Hexamer
“Normal” absorption
• Onset: 30 min
• Peak: 2 hr
• Duration: 6-8 hr
42
Q

Insulin Lispro:
What configuration?
slow, normal or rapid absorption?
Onset is how long? peak? duration?

A
Dimers
Rapid
15min
30min
4hr
43
Q

Insulin analogues are amino acid substitutions. These substitutions affect what? (3)

A

Quaternary structure
Crystallization properties
Solubility

44
Q

Which has slower absorption between the following:
Dimer vs. Hexamer
Crystallization High vs. Low
Solubility High vs. Low

A

Hexamer
High
Low

45
Q

NPH : rapid, short, intermediate or long PK?

A

Intermediate

46
Q

Glargine : rapid, short, intermediate or long PK?

A

Long

47
Q

Example of GSIS replacement drug that will induce rapid/regular acting insulin?
What do these mimic?

A

Lispro

Mimics beta cell release of insulin in response to nutrient load

48
Q

Example of basal insulin replacement drug that will induce intermediate/long acting insulin?
This provides constant ____ levels
Important to prevent _____ release from liver during fasting

A

NPH
Insulin
glucose release

49
Q

The dosage of GSIS/basal replacement depends on what? (2)

If not, there is risk for what disease?

A

Carb intake and physical activity

Risk for hypoglycemia

50
Q

Insulin infusion devices:

which two manually monitor glucose?

A

Traditional Insulin Replacement

Insulin Infusion Pump

51
Q

Insulin infusion devices:

Which one requires manual injection?

A

Traditional insulin replacement

52
Q

Insulin Infusion devices:

Which two have automated delivery?

A

Insulin Infusion Pump

Artificial Pancreas

53
Q

Insulin Infusion devices:

Which one has automated glucose monitoring?

A

Artificial Pancreas

54
Q

Most common and severe adverse effect associated with insulin replacement therapy?

A

Hypoglycemia

55
Q

Common causes of hypoglycemia? (3)

What is the treatment for acute hypoglycemia?

A

Inadequate carb intake, unusual physical activity, insulin dose too large

Treatment : glucose

56
Q

What is the most common adverse effect of insulin replacement therapy? Why?

A

Weight gain

Because insulin is an anabolic hormone and promotes energy storage

57
Q

What is the drug of choice for type II diabetes?

A

Metformin

58
Q

Metformin activates which enzyme? This increases insulin sensitivity in which tissues?
What effect does this have?

A

AMP-dependent kinase (AMPK)
Liver, Fat, Skeletal muscle
Decreases basal and post-prandial blood glucose

59
Q

Most common adverse effect of metformin?
Most severe?
Has low risk for ________

A

GI irritation
Lactic acidosis
Hypoglycemia

60
Q

MOA of insulin secretagogues? (4)

A
  1. Inhibits ATP-sensitive K+ channels in pancreatic B-cells
  2. Cell depolarization
  3. Opening of voltage-sensitive Ca2+ channels
  4. Exocytic insulin secretion
    (Compensates for insulin resistance)
61
Q

Two insulin secretagogues?

A

Sulfonylureas

Meglitinides

62
Q

Incretins regulate the release of what? (2)

A

Pancreatic insulin and glucagon

63
Q

MOA of glucose before administration of incretins?

*remember it acts of a-cells and B-cells

A

After oral intake:

  1. Release of GLP-1 from GIT into bloodstream
  2. GLP-1 acts on receptors on a cells or B cells
  3. a cells : decrease in glucagon, decreased glucose production in liver
  4. B cells: Increase in insulin, increased glucose uptake in fat and muscle
64
Q

Dose GLP-1 promote BASAL or GLUCOSE-STIMULATED insulin secretion?

A

Glucose-stimulated

65
Q

Temporal and Contextual control of GLP-1?

A

Temporal : released from intestine in response to glucose ingestion, degraded by DDP-4
Contextual : insulin release only when glucose is >4mmol

66
Q

What degrades GLP-1?

A

DPP-4 : Dipeptidyl peptidase-4

67
Q

What type of incretin agents can reduce GLP-1 degradation?

Example?

A

DPP-4 inhibitors

Ex : Sitagliptin

68
Q

What is the effect of DPP-4 Inhibitors AND Incretin Mimetics on pancreatic GSIS insulin release and glucagon release?

A

Increases pancreatic GSIS insulin release

Reduces glucagon release

69
Q

DPP-4 inhibitors and Incretin Mimetics are used in combination with what drugs? (2)

A

Metformin

Secretagogues

70
Q

What type of incretin agents can activate pancreas GLP-1 receptors?
Example?

A

Incretin mimetics

Ex : Exenatide

71
Q

Administration of:
DPP-4 inhibitors?
Incretin mimetics?

A

DPP : oral

Mimetics : subcutaneous injection

72
Q

Major role of Gliflozins?

Two examples of this drug?

A

Inhibits Renal Glucose Reabsorption
Dapagliflozin
Canagliflozin

73
Q

MOA of gliflozins?

Effects under normoglycemic conditions and hyperglycemic conditions?

A

Inhibition of sodium-glucose transporter linked transporter 2 (SGLT2)

  • Normoglycemic : almost all glucose filtered at glomerulus is reabsorbed from renal proximal tubule by SGLT2
  • Hyperglycemic: SGLT2 can be saturated leading to glucose excretion in urine